Caseware UK (AP4) 2024.0.164 2024.0.164 2025-07-312025-07-31No description of principal activityfalse12024-08-01true1falsetrue 06961281 2024-07-31 06961281 2024-08-01 2025-07-31 06961281 2023-08-01 2024-07-31 06961281 2025-07-31 06961281 c:Director1 2024-08-01 2025-07-31 06961281 d:CurrentFinancialInstruments 2025-07-31 06961281 d:CurrentFinancialInstruments 2024-07-31 06961281 c:OrdinaryShareClass1 2024-08-01 2025-07-31 06961281 c:OrdinaryShareClass1 2025-07-31 06961281 c:OrdinaryShareClass1 2024-07-31 06961281 c:EntityHasNeverTraded 2024-08-01 2025-07-31 06961281 c:FRS102 2024-08-01 2025-07-31 06961281 c:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 06961281 c:FullAccounts 2024-08-01 2025-07-31 06961281 c:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 06961281 e:PoundSterling 2024-08-01 2025-07-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 06961281










STERADOL LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 JULY 2025



 
STERADOL LIMITED
REGISTERED NUMBER: 06961281

BALANCE SHEET
AS AT 31 JULY 2025

2025
2024
Note
£
£

  

  

Current assets
  

Debtors: amounts falling due within one year
 4 
100
100

  
100
100

Total assets less current liabilities
  
 
 
100
 
 
100

  

  

  

Net assets excluding pension asset
  
100
100

Net assets
  
100
100


Capital and reserves
  

Called up share capital 
 5 
100
100

  
100
100


For the year ended 31 July 2025 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 


D M Wightman
Director

Date: 16 January 2026

The notes on pages 2 to 3 form part of these financial statements.

Page 1

 
STERADOL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

1.


General information

Steradol Limited is a limited laibility company incorporated in England and Wales. The address of its registered office and principal place is Apex, Forbury Road, Reading, Berkshire, RG1 1AX.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

 
2.2

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.3

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).

Page 2

 
STERADOL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025

4.


Debtors

2025
2024
£
£


Other debtors
100
100

100
100



5.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



100 (2024 - 100) Ordinary shares of £1.00 each
100
100


Page 3